These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 16166319

  • 1. Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model.
    Bartholomeusz C, Itamochi H, Yuan LX, Esteva FJ, Wood CG, Terakawa N, Hung MC, Ueno NT.
    Cancer Res; 2005 Sep 15; 65(18):8406-13. PubMed ID: 16166319
    [Abstract] [Full Text] [Related]

  • 2. E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway.
    Ueno NT, Bartholomeusz C, Herrmann JL, Estrov Z, Shao R, Andreeff M, Price J, Paul RW, Anklesaria P, Yu D, Hung MC.
    Clin Cancer Res; 2000 Jan 15; 6(1):250-9. PubMed ID: 10656456
    [Abstract] [Full Text] [Related]

  • 3. HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model.
    Zhang Y, Yu D, Xia W, Hung MC.
    Oncogene; 1995 May 18; 10(10):1947-54. PubMed ID: 7761095
    [Abstract] [Full Text] [Related]

  • 4. SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu.
    Wen CC, Cheng SA, Hsuen SP, Huang YL, Kuo ZK, Lee HF, Kuo CH, Du JL, Wang WB.
    Cancer Res; 2006 Jun 01; 66(11):5847-57. PubMed ID: 16740724
    [Abstract] [Full Text] [Related]

  • 5. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
    Chang JY, Xia W, Shao R, Sorgi F, Hortobagyi GN, Huang L, Hung MC.
    Oncogene; 1997 Feb 06; 14(5):561-8. PubMed ID: 9053854
    [Abstract] [Full Text] [Related]

  • 6. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D, Wolf JK, Scanlon M, Price JE, Hung MC.
    Cancer Res; 1993 Feb 15; 53(4):891-8. PubMed ID: 8094034
    [Abstract] [Full Text] [Related]

  • 7. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y, Shen K, He CX.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep 15; 42(9):617-22. PubMed ID: 17983518
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15.
    Bartholomeusz C, Itamochi H, Nitta M, Saya H, Ginsberg MH, Ueno NT.
    Oncogene; 2006 Jan 05; 25(1):79-90. PubMed ID: 16170361
    [Abstract] [Full Text] [Related]

  • 9. Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu.
    Yu D, Matin A, Xia W, Sorgi F, Huang L, Hung MC.
    Oncogene; 1995 Oct 05; 11(7):1383-8. PubMed ID: 7478560
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y, Shen K, Yu JR.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 06; 87(41):2919-24. PubMed ID: 18261307
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of intratracheal lung cancer development by systemic delivery of E1A.
    Chang JY, Xia W, Shao R, Hung MC.
    Oncogene; 1996 Oct 03; 13(7):1405-12. PubMed ID: 8875978
    [Abstract] [Full Text] [Related]

  • 13. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice.
    Naumann U, Bähr O, Wolburg H, Altenberend S, Wick W, Liston P, Ashkenazi A, Weller M.
    Gene Ther; 2007 Jan 03; 14(2):147-61. PubMed ID: 16957768
    [Abstract] [Full Text] [Related]

  • 14. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
    Zhang Y, Gu J, Zhao L, He L, Qian W, Wang J, Wang Y, Qian Q, Qian C, Wu J, Liu XY.
    Cancer Res; 2006 Apr 15; 66(8):4291-8. PubMed ID: 16618754
    [Abstract] [Full Text] [Related]

  • 15. [Down regulation of HER2/neu expression by adenovirus E1A and its anti-tumor activity].
    Lu H, Qin H, Zhang Y.
    Zhonghua Zhong Liu Za Zhi; 2000 Sep 15; 22(5):370-3. PubMed ID: 11778270
    [Abstract] [Full Text] [Related]

  • 16. E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs.
    Zhou Z, Jia SF, Hung MC, Kleinerman ES.
    Cancer Res; 2001 Apr 15; 61(8):3394-8. PubMed ID: 11309298
    [Abstract] [Full Text] [Related]

  • 17. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
    McKay TR, Bell S, Tenev T, Stoll V, Lopes R, Lemoine NR, McNeish IA.
    Oncogene; 2003 Jun 05; 22(23):3539-47. PubMed ID: 12789262
    [Abstract] [Full Text] [Related]

  • 18. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
    Liao Y, Zou YY, Xia WY, Hung MC.
    Cancer Gene Ther; 2004 Sep 05; 11(9):594-602. PubMed ID: 15272313
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress HER2/neu.
    Roh H, Pippin J, Drebin JA.
    Cancer Res; 2000 Feb 01; 60(3):560-5. PubMed ID: 10676637
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.